FMR LLC cut its holdings in shares of LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 9.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 33,265,486 shares of the company's stock after selling 3,547,339 shares during the quarter. FMR LLC owned approximately 8.69% of LifeStance Health Group worth $245,167,000 as of its most recent SEC filing.
Other institutional investors have also recently made changes to their positions in the company. The Manufacturers Life Insurance Company raised its position in shares of LifeStance Health Group by 10.5% during the third quarter. The Manufacturers Life Insurance Company now owns 81,741 shares of the company's stock valued at $572,000 after buying an additional 7,798 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in LifeStance Health Group by 10.4% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 516,819 shares of the company's stock valued at $3,618,000 after acquiring an additional 48,634 shares during the last quarter. State Street Corp lifted its stake in LifeStance Health Group by 4.7% in the 3rd quarter. State Street Corp now owns 2,750,656 shares of the company's stock worth $19,255,000 after purchasing an additional 122,844 shares in the last quarter. Wellington Management Group LLP boosted its holdings in shares of LifeStance Health Group by 15.2% during the 3rd quarter. Wellington Management Group LLP now owns 4,830,441 shares of the company's stock valued at $33,813,000 after purchasing an additional 638,385 shares during the last quarter. Finally, Geode Capital Management LLC grew its position in shares of LifeStance Health Group by 26.8% during the third quarter. Geode Capital Management LLC now owns 3,452,178 shares of the company's stock valued at $24,170,000 after purchasing an additional 729,794 shares in the last quarter. Hedge funds and other institutional investors own 85.50% of the company's stock.
LifeStance Health Group Trading Down 0.4 %
Shares of LifeStance Health Group stock traded down $0.03 on Tuesday, reaching $6.82. The company had a trading volume of 907,723 shares, compared to its average volume of 1,607,408. The firm has a market cap of $2.62 billion, a price-to-earnings ratio of -26.23 and a beta of 1.30. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.32 and a quick ratio of 1.32. The firm's 50-day moving average price is $7.25 and its two-hundred day moving average price is $7.33. LifeStance Health Group, Inc. has a 1 year low of $4.64 and a 1 year high of $8.61.
Insider Buying and Selling
In other news, insider Lisa K. Miller sold 18,845 shares of the stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $6.90, for a total value of $130,030.50. Following the sale, the insider now directly owns 339,810 shares in the company, valued at approximately $2,344,689. This represents a 5.25 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 6.60% of the stock is owned by corporate insiders.
Wall Street Analyst Weigh In
LFST has been the topic of a number of research analyst reports. William Blair reiterated an "outperform" rating on shares of LifeStance Health Group in a research report on Friday, February 28th. Canaccord Genuity Group assumed coverage on LifeStance Health Group in a report on Thursday, April 3rd. They set a "buy" rating and a $8.00 price objective on the stock. KeyCorp initiated coverage on LifeStance Health Group in a research report on Tuesday, April 8th. They set an "overweight" rating and a $9.00 target price for the company. Finally, The Goldman Sachs Group upgraded shares of LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $10.00 price target on the stock in a research report on Monday, December 16th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, four have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $8.58.
Check Out Our Latest Report on LFST
About LifeStance Health Group
(
Free Report)
LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.
Featured Stories
Before you consider LifeStance Health Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and LifeStance Health Group wasn't on the list.
While LifeStance Health Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
